Brean Capital analyst Difei Yang was out today with a few insights on Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), following the news that the U.
Morningstar Siemens AG (ADR) (OTC MKTS:SIEGY) delivered mixed second-quarter results as profit of industrial business declined 5% year on year in light of flat …
